Home
>
National Drug Code (NDC)
>
METHIMAZOLE
METHIMAZOLE - 64376-655-01 - (METHIMAZOLE)
Drug Information of METHIMAZOLE
| Product NDC: | 64376-655 |
| Proprietary Name: | METHIMAZOLE |
| Non Proprietary Name: | METHIMAZOLE |
| Active Ingredient(s): | 5 mg/1 & nbsp; METHIMAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of METHIMAZOLE
| Product NDC: | 64376-655 |
| Labeler Name: | Boca Pharmacal, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202068 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120307 |
Package Information of METHIMAZOLE
| Package NDC: | 64376-655-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (64376-655-01) |
NDC Information of METHIMAZOLE
| NDC Code | 64376-655-01 |
| Proprietary Name | METHIMAZOLE |
| Package Description | 100 TABLET in 1 BOTTLE (64376-655-01) |
| Product NDC | 64376-655 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | METHIMAZOLE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120307 |
| Marketing Category Name | ANDA |
| Labeler Name | Boca Pharmacal, Inc. |
| Substance Name | METHIMAZOLE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
